影响侵入性粘膜腺癌存活率的人口和预后因素:国家癌症数据库分析
Michael Richard Demangone1, Beau Hsia2, Augustus Malan2
1University of Arizona College of Medicine -Phoenix, Phoenix, AZ, USA. michaeldemangone@arizona.edu.
Medical oncology (Northwood, London, England)
|May 28, 2025
概括
侵入性粘膜腺癌 (IMA) 的存活率受到年龄,性别,收入和保险的影响. 女性患者和私人保险患者通常经历更好的结果,而年龄较大和缺乏放射治疗与预后较差有关.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 流行病学 流行病学
背景情况:
- 侵入性粘膜腺癌 (IMA) 是一种罕见的肺瘤,由于其稀有性,其结果定义不佳.
- 独特的组织学包括杯状和柱状细胞,具有多样化的生长模式.
研究的目的:
- 调查影响侵袭性粘膜腺癌患者整体生存率和死亡率的人口统计和预后因素.
- 使用国家癌症数据库 (NCDB) 分析生存数据.
主要方法:
- 利用2004-2020年国家癌症数据库 (NCDB),通过ICD-O-3代码8253.3识别了6202名侵入性粘膜腺癌患者.
- 采用卡普兰-梅尔,日志等级测试和考克斯回归模型进行时间到事件结果分析.
主要成果:
- 年龄较大与生存率较低相关 (10年生存率:12.4%).
- 女性患者的生存率明显优于男性 (p < 0.001).
- 较低的收入,医疗补助保险和缺乏放射治疗与增加的死亡率和较差的生存率有关 (HRs从1.35到1.46).
结论:
- 年龄,性别,种族和社会经济地位等人口因素显著影响侵袭性粘膜腺癌的预后.
- 保险状况和治疗方式,如放射治疗,是IMA患者生存结果的关键决定因素.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


